Month: December 2020

Preliminary data from the Phase 1 trial are expected first half 2021Additional €3.4 million in non-dilutive funding from SPW-Recherche of the Walloon Region to support advancement of CYAD-211MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2020 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced dosing of the first patient of the Phase 1 IMMUNICY-1 trial of CYAD-211, the Company’s novel, short hairpin RNA (shRNA)-based anti-B-cell maturation antigen (BCMA) candidate for the treatment of relapsed/refractory multiple myeloma (r/r MM).“Despite the introduction of several new treatment options over the past few years, multiple myeloma remains a devastating disease with...

ROTTERDAM, The Netherlands (4 December 2020) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announced the acquisition of two speciality distribution companies in Mexico, Millikan S.A. de C.V. (“Millikan”) and Banner Química S.A. de C.V. (“Banner Química”).  “It has been a very active year for our IMCD Mexico team, and we are pleased to maintain our growth momentum with the acquisitions of Millikan and Banner Química in this important Latin American market,” said Marcus Jordan, Americas President, IMCD. “Both companies perfectly complement our existing operations in Mexico and strengthen our technical and commercial offering in a number of core market segments.”Both based in Mexico City, Millikan and Banner Química collectively generated a revenue of USD 15 million in 2019 and add...

Las Vegas, NV, Dec. 04, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP) announced that it has settled the longstanding 5-year old SEC civil case. Hemp, Inc. and Bruce Perlowin have agreed to settle the civil suit against them without admitting or denying the SEC’s allegations.  Perlowin is transitioning from CEO to Chief Visionary Consultant (CVC) and will not be managing the day-to-day tasks of the company. He will, however, remain as the true visionary Hemp, Inc. shareholders have come to admire and respect.The Company remains committed to its longstanding goals and will be aggressively moving forward to add new blood and new ideas to the management of the company. In the first quarter 2021, Hemp, Inc. will expand its knowledge base by bringing in a new CEO and new members of its Board of Directors.WHAT...

Alter Securities, a developer of innovative financial products and technology, today announces launching of as.exchange trading platform. as.exchange is the only venue where Tranched Value Securities (patent pending) will be offered, alongside with other new derivatives in the near future, which are expected to enhance traders’ risk management, returns and contribute to more efficient markets. as.exchange currently is the only company around the globe providing OTC cryptocurrency derivatives trading to retail users, as well as institutional investors. Unlike other cryptocurrency derivative exchanges, as.exchange is the only one that offers patented financial products. This sets as.exchange apart from the major competitors, making the products offered beneficial even to the other cryptocurrency exchanges for the purposes of liquidity enhancement...

You will agree that one of the most stressful things in life is not having enough money when you need it the most. Life is full of unexpected surprises and despite the fact that you are a prudent saver life throws sudden expenses and surprises you off-guard. If you need a small loan amount and your near and dear ones are not in a position to lend it you can approach online payday loans Canada at Payday Rooster. Payday Rooster is an online platform, helping people who wish to apply for instant payday loans Canada. You can fill an application form on the website of Payday Rooster which forwards your application to the lenders in its network. The team at Payday Rooster developed a unique system of lending exclusively via the Internet which has proven to be the most cost-effective, efficient, and fastest way of obtaining payday loans to date. Without...

上海, Dec. 04, 2020 (GLOBE NEWSWIRE) — 全球知名的工作场所文化评估和认证机构卓越职场®经评估，将凯斯纽荷兰工业集团中国（所有全资子公司）列入2020年大中华区最佳职场™榜单。最佳职场认证需要通过双重评估：其一是信任指数©员工调查，衡量员工对公司领导力、组织文化和信任度的看法；其二是文化审计©问卷，由受评估公司提交，概述公司现行政策与措施。参与公司必须在信任指数员工调查中整体得分高于70%的门槛值，并且符合其他标准，同时满足文化审计评估的要求，才能获得大中华区最佳职场的认证。凯斯纽荷兰工业集团中国的主要优势包括推进公司包容性文化建设，以及为员工提供多元文化背景下跨国团队协同合作的工作环境。评估还体现了公司注重培养员工对公司的归属感和向心力，员工在为集体成就感到自豪的同时，愿意不断超越自我支持团队发展。此外，公司还为员工提供优质和安全的工作环境，确保员工可以跨部门跨地区高度参与其中。凯斯纽荷兰工业集团中国区总裁卢卡·马纳蒂(Luca Mainardi)表示：“因为全体员工对公司的坚定支持与奉献精神，我们才获得了卓越职场这一重要认可。只有我们始终上下一心，坚持践行公司的价值观，我们才能获得成功，让凯斯纽荷兰工业集团中国成为最佳职场。今后我们仍将继续努力，进一步加强员工的参与度，提升员工工作体验。”凯斯纽荷兰工业集团旗下有十二个品牌，其中七个在中国运营，业务涉及农业机械、工程机械、商用车与动力总成。此外，集团旗下设立凯斯纽荷兰金融服务为各业务板块提供金融支持，后市场部门为客户提供完善的配件与服务。凯斯纽荷兰工业集团在中国还设有三家合资企业，包括合资企业在内集团在中国员工总数约为9,600人，设有五家生产工厂和五个研发中心。注册获取凯斯纽荷兰工业集团新闻通知: https://media.cnhindustrial.com/AMEA-CHINESE/Subscribe凯斯纽荷兰工业集团（纽交所代码：CNHI /米兰证券交易所代码：CNHI）是全球资本货物行业的领军企业之一，具备领先的行业经验与丰富的产品类别，业务版图覆盖全球。公司旗下品牌在各行业都处于国际领先水平：包括农业机械行业的Case...

CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the pricing of its upsized initial public offering of 7,000,000 shares of its common stock at a public offering price of $18.00 per share. All of the shares are being offered by Sigilon. In addition, Sigilon has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Sigilon’s common stock is expected to begin trading on the Nasdaq Global Market on December 4, 2020 under the symbol “SGTX.”The gross proceeds of the offering, before deducting underwriting discounts and...

TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) — dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) is pleased to announce the results of the annual and special meeting of its shareholders, which was completed today (the “Meeting”). Out of concern for the safety of dynaCERT‘s employees, shareholders and other stakeholders in light of the COVID‐19 pandemic, and in accordance with current public health rules and guidelines concerning in‐person gatherings, the Meeting was held virtually via the Lumi annual meeting platform pursuant to suggestions by the Company’s registrar and transfer agent and scrutineers, TSX Trust Company. A total of 106,024,254 common shares of the Company (each, a “Common Share”), representing 28.85% of the total Common Shares outstanding, were...

—Significant and sustained reduction in HAE attacks——Oral, once-daily prophylactic option enables HAE patients to reduce burden of therapy1 ——ORLADEYO approved for adult and pediatric patients 12 years and older—RESEARCH TRIANGLE PARK, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S. Food and Drug Administration (FDA) has approved oral, once-daily ORLADEYO™ (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.“ORLADEYO offers people with HAE and their physicians the first orally administered non-steroidal option for preventing HAE attacks and represents an important and welcome step in making more treatment options available to physicians and patients,” said Anthony J. Castaldo, president...

SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Juniper Networks, Inc. (NYSE: JNPR) (“Juniper”), a leader in secure, AI-driven networks, has priced an underwritten public offering of $400 million of 1.200% Senior Notes due 2025 (the “2025 Notes”) and $400 million of 2.000% Senior Notes due 2030 (the “2030 Notes” and, together with the 2025 Notes, the “Notes”). The offering is expected to close on December 10, 2020, subject to the satisfaction of customary closing conditions. The 2025 Notes were issued at 99.976% of par value, bear interest at an annual rate of 1.200% and will mature on December 10, 2025. The 2030 Notes were issued at 99.811% of par value, bear interest at an annual rate of 2.000% and will mature on December 10, 2030.Juniper estimates that the net proceeds of the sale of the Notes, after deducting the underwriter...